Calambro, Nelson C.
HRN: 26-71-73 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2025
CEFTRIAXONE 1G (VIAL)
02/18/2025
02/24/2025
IV
1g
Q12
TB Osteomyelitis, Left Ankle
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes